Digestive Diseases, Yale School of Medicine, New Haven, Connecticut, USA.
Clin Gastroenterol Hepatol. 2012 Jan;10(1):58-64.e1. doi: 10.1016/j.cgh.2011.07.005. Epub 2011 Jul 23.
BACKGROUND & AIMS: Colonoscopy is a recommended component of screening for colorectal cancer. We conducted a retrospective study of Medicare data to determine the frequency of anesthesiologist involvement and to identify patient and provider characteristics and cost implications associated with anesthesiologist involvement.
We used the linked Surveillance, Epidemiology, and End Results Medicare dataset to identify patients without cancer who received a screening colonoscopy examination from July 2001 through 2006 (n = 16,268). The outcome variable was anesthesiologist involvement, which was identified by searching Medicare claims. Logistic regression was used to explore the association between patient and provider characteristics and anesthesiologist involvement. Costs associated with the use of an anesthesiologist were derived based on a cost assessment by the Agency for Healthcare Research and Quality.
Of the screening colonoscopies assessed, 17.2% involved an anesthesiologist. The screening colonoscopy rate more than doubled during the study period. The frequency of anesthesiologist involvement increased from 11.0% of screening colonoscopies in 2001 to 23.4% in 2006. Surgeons involved an anesthesiologist in 24.2% of colonoscopies, compared with 18.0% of gastroenterologists and 11.3% of primary care providers. The percentage of colonoscopies that involved an anesthesiologist varied among regions, ranging from 1.6% in San Francisco to 57.8% in New Jersey. Anesthesiologist involvement increased the cost by approximately 20% per screening colonoscopy.
An increase in the involvement of anesthesiologists has significantly increased the cost of screening colonoscopies. Studies are needed to assess the effects of anesthesiologists on risks and benefits of colonoscopy, to determine the most safe and cost-effective approaches.
结肠镜检查是结直肠癌筛查的推荐项目。我们对医疗保险数据进行了回顾性研究,以确定麻醉师参与的频率,并确定与麻醉师参与相关的患者和提供者特征及成本影响。
我们使用监测、流行病学和最终结果医疗保险数据集,确定 2001 年 7 月至 2006 年间没有癌症且接受筛查性结肠镜检查的患者(n=16268)。结局变量为麻醉师参与情况,通过查阅医疗保险索赔确定。采用 logistic 回归探讨患者和提供者特征与麻醉师参与之间的关系。根据医疗保健研究与质量局的成本评估,得出与使用麻醉师相关的成本。
在所评估的筛查性结肠镜检查中,17.2%涉及麻醉师。研究期间,筛查性结肠镜检查率翻了一番多。麻醉师参与的频率从 2001 年筛查性结肠镜检查的 11.0%增加到 2006 年的 23.4%。外科医生在 24.2%的结肠镜检查中涉及麻醉师,而胃肠病学家为 18.0%,初级保健提供者为 11.3%。麻醉师参与的结肠镜检查百分比在不同地区有所不同,从旧金山的 1.6%到新泽西州的 57.8%。麻醉师参与使每例筛查性结肠镜检查的成本增加了约 20%。
麻醉师参与的增加显著增加了筛查性结肠镜检查的成本。需要研究麻醉师对结肠镜检查风险和获益的影响,以确定最安全和最具成本效益的方法。